Exhibit 99.1
THERATECHNOLOGIES ANNOUNCES THE RESIGNATION OF ONE OF ITS
DIRECTORS, MR. ALAIN TRUDEAU
Montreal, Canada February 29, 2024 Theratechnologies Inc. (Theratechnologies or the
Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Mr. Alain Trudeau has resigned from the Board of Directors of
Theratechnologies and as a member of its Audit Committee, effective immediately.
I want to thank Alain for his contributions to
Theratechnologies as a director since joining the Company in October 2020 and for completing the annual review for the 2023 fiscal year, said Dawn Svoronos, Chair of the Board at Theratechnologies. Alain was the current Chair of the
Audit Committee and, during his tenure as a Board member, he was also a member of the Compensation Committee from May 2021 until March 2023.
Consistent with past practices, the Board of Directors of the Company will assess whether it will appoint a new member to fill this vacancy at the Board
before the next annual meeting of shareholders.
The Board has appointed Frank Holler as Chair of the Audit Committee and plans to appoint a new
independent director to this committee in order to ensure compliance with securities regulation.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies
addressing unmet medical needs. Further information about Theratechnologies is available on the Companys website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on
LinkedIn and X (formerly Twitter).
Forward-Looking Information
This press release contains forward-looking statements and forward-looking information (collectively, Forward-Looking Statements), within the
meaning of applicable securities laws, that are based on our managements beliefs and assumptions and on information currently available to our management. You can identify Forward-Looking Statements by terms such as may,
will, should, could, would, outlook, believe, plan, envisage, anticipate, expect and estimate, or the negatives of
these terms, or variations of them. The Forward-Looking Statements contained in this press release include, but are not limited to, statements regarding the assessment by the Board of Directors of the Company about the appointment of a new member to
the board. Although the Forward-Looking Statements contained in this press release are based upon what the Company believes are reasonable assumptions in light of the information currently available, investors are cautioned against placing undue
reliance on these
1